[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100491922":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":19,"locations":25,"responsibleParty":321,"collaborators":18,"id":323,"slug":18,"hasResults":324,"nctId":325,"briefTitle":326,"officialTitle":326,"acronym":327,"eligibilityCriteria":328,"healthyVolunteers":324,"sex":329,"minAge":330,"maxAge":18,"enrollmentInfo":331,"targetDuration":18,"studyType":334,"phases":335,"briefSummary":337,"conditions":338,"keywords":18,"overallStatus":28,"whyStopped":18,"lastUpdateSubmitDate":343,"lastUpdatePostDateStruct":344,"startDateStruct":347,"completionDateStruct":349,"leadSponsor":351,"locationsCount":352},{"fullName":5,"class":6},"Valencia Technologies Corporation","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"eCoin Tibial Nerve Stimulation","EXPERIMENTAL","Subcutaneous stimulation of the tibial nerve using the eCoin device.",[13],"Device: eCoin Tibial Nerve Stimulation",[15],{"type":16,"name":9,"description":11,"armGroupLabels":17,"otherNames":18},"DEVICE",[9],null,[20],{"name":21,"role":22,"phone":23,"phoneExt":18,"email":24},"Dylan Beyer","CONTACT","8019207775","dbeyer@valenciatechnologies.com",[26,42,52,67,81,94,107,124,141,155,171,184,198,211,222,236,250,263,273,287,300,313],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Urology Centers of Alabama","RECRUITING","Homewood","Alabama","35209","United States",{"type":34,"coordinates":35},"Point",[36,37],-86.80082,33.47177,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":18,"phoneExt":18,"email":18},"Alison Pickering, MD",{"facility":43,"status":44,"city":45,"state":30,"zip":46,"country":32,"cosmosGeoPoint":47,"geoPoint":51,"contacts":18},"USA Health","WITHDRAWN","Mobile","36606",{"type":34,"coordinates":48},[49,50],-88.04305,30.69436,{"lat":50,"lon":49},{"facility":53,"status":28,"city":54,"state":55,"zip":56,"country":32,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Arkansas Urology","Little Rock","Arkansas","72211",{"type":34,"coordinates":58},[59,60],-92.28959,34.74648,{"lat":60,"lon":59},[63,65],{"name":64,"role":22,"phone":18,"phoneExt":18,"email":18},"Lauren Hendrix, MD",{"name":64,"role":66,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"facility":68,"status":28,"city":69,"state":70,"zip":71,"country":32,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"University of California, Irvine","Irvine","California","92697",{"type":34,"coordinates":73},[74,75],-117.82311,33.66946,{"lat":75,"lon":74},[78,80],{"name":79,"role":22,"phone":18,"phoneExt":18,"email":18},"Dena Moskowitz, MD",{"name":79,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":82,"status":28,"city":83,"state":70,"zip":84,"country":32,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"AIR Research","Los Angeles","90017",{"type":34,"coordinates":86},[87,88],-118.24368,34.05223,{"lat":88,"lon":87},[91,93],{"name":92,"role":22,"phone":18,"phoneExt":18,"email":18},"John Kowalczyk, DO",{"name":92,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":95,"status":28,"city":96,"state":70,"zip":97,"country":32,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Stanford Health","Stanford","94305",{"type":34,"coordinates":99},[100,101],-122.16608,37.42411,{"lat":101,"lon":100},[104,106],{"name":105,"role":22,"phone":18,"phoneExt":18,"email":18},"Craig Comiter, MD",{"name":105,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":108,"status":28,"city":109,"state":110,"zip":111,"country":32,"cosmosGeoPoint":112,"geoPoint":116,"contacts":117},"Urological Research Network Corp","Hialeah","Florida","33016",{"type":34,"coordinates":113},[114,115],-80.27811,25.8576,{"lat":115,"lon":114},[118,122],{"name":119,"role":22,"phone":120,"phoneExt":18,"email":121},"Isabel H Lopez, MBA","786-431-2014","isabel@besturology.net",{"name":123,"role":66,"phone":18,"phoneExt":18,"email":18},"Edward Gheiler, MD",{"facility":125,"status":28,"city":126,"state":127,"zip":128,"country":32,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"The Emory Clinic","Atlanta","Georgia","30322",{"type":34,"coordinates":130},[131,132],-84.38798,33.749,{"lat":132,"lon":131},[135,139],{"name":136,"role":22,"phone":137,"phoneExt":18,"email":138},"Mersiha Torlak","404-778-4823","mersiha.torlak@emory.edu",{"name":140,"role":66,"phone":18,"phoneExt":18,"email":18},"Brendan Browne, MD",{"facility":142,"status":28,"city":143,"state":144,"zip":145,"country":32,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"Rush University","Chicago","Illinois","60612",{"type":34,"coordinates":147},[148,149],-87.65005,41.85003,{"lat":149,"lon":148},[152,154],{"name":153,"role":22,"phone":18,"phoneExt":18,"email":18},"Sarah Adelstein, MD",{"name":153,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":156,"status":28,"city":157,"state":158,"zip":159,"country":32,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"The Iowa Clinic","Ankeny","Iowa","50023",{"type":34,"coordinates":161},[162,163],-93.60577,41.72971,{"lat":163,"lon":162},[166,170],{"name":167,"role":22,"phone":168,"phoneExt":18,"email":169},"Stephanie Morgan, MD","515-875-9815","spmorgan@iowaclinic.com",{"name":167,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":172,"status":28,"city":173,"state":158,"zip":174,"country":32,"cosmosGeoPoint":175,"geoPoint":179,"contacts":180},"University of Iowa","Iowa City","52242",{"type":34,"coordinates":176},[177,178],-91.53017,41.66113,{"lat":178,"lon":177},[181,183],{"name":182,"role":22,"phone":18,"phoneExt":18,"email":18},"Annah Vollstedt, MD",{"name":182,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":185,"status":28,"city":186,"state":187,"zip":188,"country":32,"cosmosGeoPoint":189,"geoPoint":193,"contacts":194},"University of Kansas Medical Center Research Institute, Inc","Kansas City","Kansas","66160",{"type":34,"coordinates":190},[191,192],-94.62746,39.11417,{"lat":192,"lon":191},[195,197],{"name":196,"role":22,"phone":18,"phoneExt":18,"email":18},"Kirk Redger, MD",{"name":196,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":199,"status":28,"city":200,"state":187,"zip":201,"country":32,"cosmosGeoPoint":202,"geoPoint":206,"contacts":207},"Cypress Medical Research","Wichita","67226",{"type":34,"coordinates":203},[204,205],-97.33754,37.69224,{"lat":205,"lon":204},[208,210],{"name":209,"role":22,"phone":18,"phoneExt":18,"email":18},"Kevin Miller, MD",{"name":209,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":212,"status":213,"city":214,"state":215,"zip":216,"country":32,"cosmosGeoPoint":217,"geoPoint":221,"contacts":18},"Louisiana State University Health Sciences Center","ACTIVE_NOT_RECRUITING","Shreveport","Louisiana","71103",{"type":34,"coordinates":218},[219,220],-93.75018,32.52515,{"lat":220,"lon":219},{"facility":223,"status":28,"city":224,"state":225,"zip":226,"country":32,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Minnesota Urology","Woodbury","Minnesota","55125",{"type":34,"coordinates":228},[229,230],-92.95938,44.92386,{"lat":230,"lon":229},[233,235],{"name":234,"role":22,"phone":18,"phoneExt":18,"email":18},"Michael Ehlert, MD",{"name":234,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":237,"status":28,"city":238,"state":239,"zip":240,"country":32,"cosmosGeoPoint":241,"geoPoint":245,"contacts":246},"Specialty Clinical Research of St. Louis","St Louis","Missouri","63141",{"type":34,"coordinates":242},[243,244],-90.19789,38.62727,{"lat":244,"lon":243},[247,249],{"name":248,"role":22,"phone":18,"phoneExt":18,"email":18},"Travis Bullock, MD",{"name":248,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":251,"status":28,"city":252,"state":252,"zip":253,"country":32,"cosmosGeoPoint":254,"geoPoint":258,"contacts":259},"Weill Cornell Medicine: Department of Urology","New York","10065",{"type":34,"coordinates":255},[256,257],-74.00597,40.71427,{"lat":257,"lon":256},[260,262],{"name":261,"role":22,"phone":18,"phoneExt":18,"email":18},"Larissa Rodriguez, MD",{"name":261,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":264,"status":213,"city":265,"state":266,"zip":267,"country":32,"cosmosGeoPoint":268,"geoPoint":272,"contacts":18},"The Oregon Clinic","Portland","Oregon","97225",{"type":34,"coordinates":269},[270,271],-122.67621,45.52345,{"lat":271,"lon":270},{"facility":274,"status":28,"city":275,"state":276,"zip":277,"country":32,"cosmosGeoPoint":278,"geoPoint":282,"contacts":283},"Southern Urogynecology","West Columbia","South Carolina","29169",{"type":34,"coordinates":279},[280,281],-81.07398,33.99349,{"lat":281,"lon":280},[284,286],{"name":285,"role":22,"phone":18,"phoneExt":18,"email":18},"Andrea Pezzella, MD",{"name":285,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":288,"status":28,"city":289,"state":290,"zip":291,"country":32,"cosmosGeoPoint":292,"geoPoint":296,"contacts":297},"UPNT Research Institute","Arlington","Texas","76017",{"type":34,"coordinates":293},[294,295],-97.10807,32.73569,{"lat":295,"lon":294},[298],{"name":299,"role":22,"phone":18,"phoneExt":18,"email":18},"Tracy Cannon-Smith, MD",{"facility":301,"status":28,"city":302,"state":290,"zip":303,"country":32,"cosmosGeoPoint":304,"geoPoint":308,"contacts":309},"Baylor College of Medicine","Houston","77030",{"type":34,"coordinates":305},[306,307],-95.36327,29.76328,{"lat":307,"lon":306},[310,312],{"name":311,"role":22,"phone":18,"phoneExt":18,"email":18},"Christopher Smith, MD",{"name":311,"role":66,"phone":18,"phoneExt":18,"email":18},{"facility":314,"status":28,"city":302,"state":290,"zip":303,"country":32,"cosmosGeoPoint":315,"geoPoint":317,"contacts":318},"The Methodist Hospital Research Institute",{"type":34,"coordinates":316},[306,307],{"lat":307,"lon":306},[319],{"name":320,"role":22,"phone":18,"phoneExt":18,"email":18},"Kathleen Kobashi, MD",{"type":322,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100491922",false,"NCT05685433","A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)","RECIPE","Inclusion Criteria:\n\n* Women and men above 18 years old with gender percentages reflective of disease prevalence in the U.S. population\n* Individual with diagnosis of overactive bladder with urgency urinary incontinence.\n* Individual has at least one urgency urinary incontinence episode on each of three days as determined on a 3-day voiding diary.\n* Individual gives written informed consent.\n* Individual is mentally competent and able to understand all study requirements.\n* Individual is willing and able to complete a 3-day voiding diary and quality of life questionnaire.\n* Individual is without pharmacological treatment of overactive bladder (anticholinergic and β3-adrenoceptor agonists) for 2 weeks prior to baseline or longer if the physician judges that the therapeutic effect is still present.\n* Individual is intolerant of or has an inadequate response to any of anticholinergics, β3-adrenoceptor agonists, onabotulinumtoxinA, or who have undergone percutaneous tibial nerve stimulation (PTNS).\n* Individual is determined to be a suitable surgical candidate by physician.\n* Individual is appropriate for eCoin treatment based on the US FDA-approved IFU requirements.\n\nExclusion Criteria:\n\n* Individual is not appropriate for eCoin therapy based upon the US FDA-approved IFU requirements.\n* Individual has clinically significant bladder outlet obstruction. (Suspected bladder outlet obstruction will be initially assessed by uroflow study with those having a maximum flow rate \\\u003C 15mL\u002Fs requiring additional evaluation.)\n* Individual has predominantly stress urinary incontinence (greater than 1\u002F3 of leaks on baseline diary are stress).\n* Individual has an active urinary tract infection at time of enrollment.\n* Individual has known polyuria.\n* Individual has significant lower urinary tract pain or has been diagnosed with interstitial cystitis or bladder pain syndrome.\n* Individual has abnormal post void residual (i.e. greater than 200 cc initially and on repeat testing after double voiding)\n* Individual has clinically significant urethral stricture disease or bladder neck contracture. (Suspected disease or contracture will be initially assessed by uroflow study with those having a maximum flow rate \\\u003C 15mL\u002Fs requiring additional evaluation.)\n* Individual has chronic venous insufficiency with a history of skin change (hyperpigmentation, lipodermatosclerosis, ulceration) in the ankle region.\n* Individual has morbid obesity and in the opinion of the investigator is not a good candidate for the study.\n* Individual has had diagnosis of bladder, urethral, or prostate cancer.\n* Individual has had a prior anti-stress incontinence sling surgery within the last year.\n* Individual is pregnant or intends to become pregnant during the study.\n* Individual has the presence of urinary fistula, bladder stone, or interstitial cystitis.\n* Individual has uncontrolled diabetes mellitus (Hemoglobin A1C\\>7) or diabetes with significant peripheral complications. (Uncontrolled diabetes will be ruled out by blood test excluding those with Hemoglobin A1C\\>7).\n* Individual has an implantable neurostimulator, pacemaker, or implantable cardiac defibrillator (ICD).\n* Individual has been treated with onabotulinumtoxinA in the previous 9 months prior to enrollment, or more time if the principal investigator judges that the therapeutic effect is present.\n* Individual has been treated with percutaneous tibial nerve stimulation (PTNS) within the previous 4 weeks prior to enrollment or more time if the principal investigator judges that the therapeutic effect is present.\n* Individual is currently using transcutaneous electrical nerve stimulation (TENS) in the pelvic region, back, or legs.\n* Individual is aware that he or she will need an MRI scan other than a head\u002Fneck\u002Fshoulder MRI during the study period.\n* Individual has a clotting or bleeding disorder or is using anticoagulant therapies and in the opinion of the investigator is not a good candidate for the study (antiplatelet and anticoagulant therapy may be continued or held at the discretion of the investigator).\n* Individual is neutropenic or immune-compromised.\n* Individual has had previous surgery and\u002For significant scarring at the implant location.\n* Individual has ongoing dermatologic condition at the implant site, including but not limited to dermatitis and autoimmune disorders.\n* Individual has a clinically significant peripheral neuropathy in the lower extremities.\n* Individual has neurogenic bladder dysfunction.\n* Individual has pitting edema at implant location (≥ 2+ is excluded).\n* Individual has inadequate skin integrity or any evidence of an infection or inflammation in either lower leg.\n* Individual has varicose veins and is symptomatic.\n* Individual has open wounds, trauma, or prior surgery in the lower extremities.\n* Individual has arterial disease in the lower extremities.\n* Individual has vasculitis in the lower extremities.\n* Individual has bladder stones or neoplasia. (Suspected bladder stones or neoplasia will be ruled out with a urine dipstick showing no more than trace blood, and microscopic analysis (which should be done in that case) shows ≥3 PBC's \u002FHPF unless that subject has been worked up and found negative for clinically significant disease such as malignant neoplasm or stones.)\n* In the opinion of the investigator, Individual is not a good candidate for participation in the study.","ALL","18 Years",{"count":332,"type":333},200,"ESTIMATED","INTERVENTIONAL",[336],"NA","A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).",[339,340,341,342],"Overactive Bladder","Urge Incontinence","Incontinence, Urinary","Urinary Urge Incontinence","2026-01-26",{"date":345,"type":346},"2026-01-28","ACTUAL",{"date":348,"type":346},"2023-01-26",{"date":350,"type":333},"2031-12",{"name":5,"class":6},22]